Shining Light on Pancreatic Cancer: Keeping You Up-to-Date and In the Know

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.

Release Date: June 15, 2016
Expiration Date: June 15, 2017

Expected time to complete this activity as designed: 75 minutes

There are no fees for participating in or receiving credit for this online activity.

Program Overview

In 2016, pancreatic cancer is expected to claim the lives of 41,780 individuals and reports the lowest survival rate of any major cancer. Are you armed with the facts and knowledge in the advances and treatment of this disease?

Advances in treatment provide hope but also increase the complexity of care for the patients. This activity will provide a look at the clinical application of new and emerging therapeutic options for advanced metastatic pancreatic cancer, as well as examine steps we as nurses can take to assure a patient-centered approach to treatment.

Target Audience

This activity is designed for oncology nurses who have an interest in enhancing their clinical skills in the management of pancreatic cancer.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Summarize current data relative to pancreatic cancer biology, risk factors, and disease progression

  • Establish an evidence-based approach to the selection of first-line treatment for newly diagnosed, advanced metastatic pancreatic cancer

  • Review new and emerging therapeutic advancements in first- and second-line therapy

  • Identify opportunities to enhance the collaborative role of the oncology nurse in establishing a comprehensive palliative care plan for patients with pancreatic cancer

Agenda

Shining Light on Pancreatic Cancer: Keeping You Up-to-Date and In the Know – Nina N. Grenon, DNP, AGCNP-BC, AOCN, Carmela L. Hoefling, MSN, APN, AOCNP, Vincent J. Picozzi, Jr., MD, MMM

Instructions for Participation and Credit

This activity is eligible for credit through June 15, 2017. After this date, this activity will expire and no further credit will be awarded.
1. Read the target audience, learning objectives, and faculty disclosures.
2. You may be asked to complete a short pre-test before accessing the educational content. This must be completed in order to move forward in the activity.
3. Complete the educational content as designed.
4. Complete the post-test. To receive a certificate, you must receive a passing score of 70%.
5. Complete the activity evaluation survey to provide feedback and information useful for future programming.
6. Certificates for CNE credit may be printed immediately after successfully completing the post-test and activity evaluation.

Faculty Biographies

Nina N. Grenon, DNP, AGCNP-BC, AOCN
Nurse Practitioner
Center for Gastrointestinal Oncology
Dana Farber Cancer Institute
Boston, Massachusetts

Nina Grenon received her diploma in nursing from Newton Wellesley Hospital School of Nursing, Newton Lower Falls, Massachusetts, her masters of science in nursing, primary health care nursing: adult/geriatric primary care, as well as her doctor of nursing practice from Simmons College, School of Nursing and Health Sciences, Boston. Ms. Grenon is a Nurse Practitioner in Gastrointestinal Oncology at Dana Farber Cancer Institute, Boston. In addition she is an Adjunct Faculty member at Simmons College, School of Nursing and Health Sciences, Boston.

Ms. Grenon holds certification as an adult nurse practitioner from the American Nursing Credentialing Center; a geriatric nurse practitioner from the American Nursing Credentialing Center; and as an advanced oncology certified nurse practitioner (AOCN®) from the Oncology Nursing Society. In addition, Ms. Grenon holds membership in the Oncology Nursing Society and the Boston Oncology Nursing Society.

Carmela L. Hoefling, MSN, APN, AOCNP
Advanced Practice Nurse
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey

Carmela Hoefling received her diploma in nursing from Elizabeth General School of Nursing and her masters of science as an adult nurse practitioner from the University of Medicine and Dentistry. She is an Advanced Practice Nurse at Rutgers Cancer Institute of New Jersey (CINJ) in New Brunswick, New Jersey, a collaborative practice involving surgical oncologist specialties in gastrointestinal, melanoma, sarcoma, and breast malignancies. Ms. Hoefling’s responsibilities include performing comprehensive health histories/physical exams, initiating and implementing individualized nursing and medical care plans, and ordering/evaluating appropriate diagnostic therapeutics. In addition she provides follow-up care, manages medical emergencies, monitors/adjusts patient medications, and provides education to the patient, family and community.

Ms. Hoefling holds Advanced Oncology Nurse Practitioner (AOCNP), and American Academy of Nurse Practitioners (AANP) certification, and is a member of the American Academy of Nurse Practitioners (AANP) and the Oncology Nursing Society (ONS).

Vincent J. Picozzi, Jr., MD, MMM
Director
Pancreas Center of Excellence
Virginia Mason Medical Center
Seattle, Washington

Dr. Vincent Picozzi received his medical degree from Stanford University in Stanford, California. He completed his internship and residency at Harvard University, Brigham and Women’s Hospital, and returned to Stanford University to complete his fellowships in hematology and oncology. In addition, Dr. Picozzi has completed a master of medical management (MMM) degree at Tulane University. He is currently Director of the Pancreas Center of Excellence at Virginia Mason Medical Center in Seattle, Washington.

Dr. Picozzi has board certification from National Board of Medical Examiners and from the American Board of Internal Medicine in internal medicine, hematology, and oncology. He holds professional memberships in the American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH), and the Pancreatic Cancer Action Network (PANCAN). He has written numerous hematology and oncology abstracts, book chapters, and peer-reviewed articles.

Serving patients with pancreaticobiliary cancer has become the primary ministry of Dr. Picozzi’s professional career. His immediate goal over the next few years is to permanently transform the perceptions and outcomes for this disorder, which has the poorest prognosis of any common cancer.

Accreditation

MediCom WOrldwide, Inc. CNE CREDIT
Accreditation Statement: MediCom Worldwide, Inc., 101 Washington Street, Morrisville, PA 19067 is approved by the California Board of Registered Nursing, Provider Number CEP11380. MediCom designates this CNE activity for 1.25 contact hours. Program Number: 16-100-029

Disclosure

As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and California State Board of Registered Nursing, MediCom Worldwide, Inc. requires everyone who is a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Accordingly, the following disclosures were made.

Faculty Disclosure

Nina N. Grenon and Carmela L. Hoeflin have disclosed no relevant financial relationships.

Dr. Vincent Picozzi Jr. has received honoraria as a consultant from AbbVie Inc. and Halozyme, Inc. He has received grant support related to research activities from Celgene Corporation, FibroGen, Inc., Immunomedics, Inc., and Phoenix Biotechnology, Inc.. He holds significant holdings in Amgen Inc., Gilead, and Johnson & Johnson Services, Inc.

Planning Committee Disclosures

The individuals listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, Executive Director, has no relevant financial relationships.

Peer Reviewer Disclosure

In accordance with MediCom Worldwide, Inc. policy, all content is independently peer reviewed for balance, objectivity and commercial bias. The peer reviewers have no relevant financial relationships to disclose.

Off-Label Disclosures/Investigational Disclosures

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Ms. Grenon and Ms. Hoefling have indicated that they do not intend to discuss off-label uses of drugs, mechanical devices, biologics or diagnostics approved by the US Food and Drug Administration (FDA) for use in the US.

Ms. Grenon and Ms. Hoefling have indicated that they do not intend to discuss investigational drugs, mechanical devices, biologics or diagnostics not approved by the FDA for use in the US.

Dr. Picozzi has indicated that he does intend to discuss off-label uses of drugs, mechanical devices, biologics or diagnostics approved by the US Food and Drug Administration (FDA) for use in the US.

Dr. Picozzi has indicated that he does intend to discuss investigational drugs, mechanical devices, biologics or diagnostics not approved by the FDA for use in the US.

Hardware/Software/Internet Requirements

MediCom Worldwide, Inc. requires Internet Explorer® version 9.0 or higher, the latest version of Google Chrome, or the latest version of Safari, a computer running Windows® Vista, Windows® 7, or Mac OS X, 512MB of RAM or greater, 1.5 GHZ or faster processor, and a screen resolution of 1024x768 or higher. Certain educational activities may require additional software to view. These activities will be marked with the information and/or links to the required software. That software may include Adobe® Flash® Player, Adobe® Acrobat®, Windows Media® Player, and/or Microsoft® Silverlight™.

If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at lisa@medicaled.com.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Celgene Corporation and Aduro Biotech.

©2016 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067, 800-408-4242.
No portion of this material may be copied or duplicated without the expressed permission of MediCom Worldwide, Inc.

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.

Partners in Pancreatic Cancer would like to recognize and thank Celgene Corporation
for their educational support of PartnersinPancreaticCancer.com.

©2017 MediCom Worldwide, Inc. All rights reserved